Feb 9, 2025 · The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly …

About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of …

Jan 1, 2015 · The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to …

Apr 15, 2025 · The World Health Organization (WHO) today released its Consolidated guidelines on tuberculosis (TB)- Module 4: treatment and care, consolidating all previous guidelines into a single …

Jan 13, 2026 · Access to appropriate medications is shown to have substantial impacts on community health and the related economic indicators. Quality-assured, safe and effective medicines, vaccines …

Other patterns of drug resistance There were an estimated 1.4 million incident cases (95% UI: 0.62–2.1 million) of isoniazid-resistant TB in 2023, including people with both rifampicin-susceptible and …

May 27, 2025 · The WHO pharmaceuticals newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world. In addition, …

Apr 29, 2025 · Lastly, some low- and middle-income CTAs reported little or no use of Reserve antibiotics, which are needed to treat infections caused by the most drug-resistant bacteria. …

Apr 15, 2025 · Module 4: treatment and care encompass all current recommendations for managing drug-susceptible and drug-resistant TB, alongside patient care and support strategies. Developed …

Nov 24, 2025 · WHO has released the Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030, a landmark roadmap to address the growing …